0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Imatinib Mesylate - Global Market Insights and Sales Trends 2024
Published Date: November 2023
|
Report Code: QYRE-Auto-2G7707
Home | Market Reports | Health| Pharmacy| Drugs & Medications
China Imatinib Mesylate Market Report Forecast 2021 2027
BUY CHAPTERS

Imatinib Mesylate - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-2G7707
Report
November 2023
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Imatinib Mesylate - Market Size

99% Purity, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period.

Imatinib Mesylate -  Market

Imatinib Mesylate - Market

The global Imatinib Mesylate market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Imatinib Mesylate in various end use industries. The expanding demands from the CML, GIST and Other,, are propelling Imatinib Mesylate market. Growth in the 98% Purity segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Imatinib Mesylate market, driven by demand from China, the second largest economy with some signs of stabilising, the Imatinib Mesylate market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Imatinib Mesylate, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Imatinib Mesylate market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Imatinib Mesylate market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Imatinib Mesylate sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Imatinib Mesylate covered in this report include GLEEVEC, Cayman Chemical, Sichuan Xieli, Nanjing Kaihua Chemical and Zhengda Tianqing, etc.
The global Imatinib Mesylate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GLEEVEC
Cayman Chemical
Sichuan Xieli
Nanjing Kaihua Chemical
Zhengda Tianqing

Scope of Imatinib Mesylate - Market Report

Report Metric Details
Report Name Imatinib Mesylate - Market
CAGR 99
Global Imatinib Mesylate market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Imatinib Mesylate market, Segment by Type:
  • 99% Purity
  • 98% Purity
  • Other
Global Imatinib Mesylate market, by Application
  • CML
  • GIST
  • Other
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Two: Detailed analysis of Imatinib Mesylate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Three: Sales, revenue of Imatinib Mesylate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
  • Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
  • Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Analysis of sales channel, distributors and customers.
  • Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What are the Application segmentation covered in the Imatinib Mesylate - Market report?

Ans: The Applications covered in the Imatinib Mesylate - Market report are CML, GIST, Other

What are the Type segmentation covered in the Imatinib Mesylate - Market report?

Ans: The Types covered in the Imatinib Mesylate - Market report are 99% Purity, 98% Purity, Other

1 Imatinib Mesylate Market Overview
1.1 Imatinib Mesylate Product Overview
1.2 Imatinib Mesylate Market Segment by Type
1.2.1 99% Purity
1.2.2 98% Purity
1.2.3 Other
1.3 Global Imatinib Mesylate Market Size by Type
1.3.1 Global Imatinib Mesylate Market Size Overview by Type (2018-2029)
1.3.2 Global Imatinib Mesylate Historic Market Size Review by Type (2018-2023)
1.3.3 Global Imatinib Mesylate Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Imatinib Mesylate Sales Breakdown by Type (2018-2023)
1.4.2 Europe Imatinib Mesylate Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Imatinib Mesylate Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Imatinib Mesylate Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Imatinib Mesylate Sales Breakdown by Type (2018-2023)
2 Global Imatinib Mesylate Market Competition by Company
2.1 Global Top Players by Imatinib Mesylate Sales (2018-2023)
2.2 Global Top Players by Imatinib Mesylate Revenue (2018-2023)
2.3 Global Top Players by Imatinib Mesylate Price (2018-2023)
2.4 Global Top Manufacturers Imatinib Mesylate Manufacturing Base Distribution, Sales Area, Product Type
2.5 Imatinib Mesylate Market Competitive Situation and Trends
2.5.1 Imatinib Mesylate Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Imatinib Mesylate Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Imatinib Mesylate as of 2022)
2.7 Date of Key Manufacturers Enter into Imatinib Mesylate Market
2.8 Key Manufacturers Imatinib Mesylate Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Imatinib Mesylate Status and Outlook by Region
3.1 Global Imatinib Mesylate Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Imatinib Mesylate Historic Market Size by Region
3.2.1 Global Imatinib Mesylate Sales in Volume by Region (2018-2023)
3.2.2 Global Imatinib Mesylate Sales in Value by Region (2018-2023)
3.2.3 Global Imatinib Mesylate Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Imatinib Mesylate Forecasted Market Size by Region
3.3.1 Global Imatinib Mesylate Sales in Volume by Region (2024-2029)
3.3.2 Global Imatinib Mesylate Sales in Value by Region (2024-2029)
3.3.3 Global Imatinib Mesylate Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Imatinib Mesylate by Application
4.1 Imatinib Mesylate Market Segment by Application
4.1.1 CML
4.1.2 GIST
4.1.3 Other
4.2 Global Imatinib Mesylate Market Size by Application
4.2.1 Global Imatinib Mesylate Market Size Overview by Application (2018-2029)
4.2.2 Global Imatinib Mesylate Historic Market Size Review by Application (2018-2023)
4.2.3 Global Imatinib Mesylate Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Imatinib Mesylate Sales Breakdown by Application (2018-2023)
4.3.2 Europe Imatinib Mesylate Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Imatinib Mesylate Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Imatinib Mesylate Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Imatinib Mesylate Sales Breakdown by Application (2018-2023)
5 North America Imatinib Mesylate by Country
5.1 North America Imatinib Mesylate Historic Market Size by Country
5.1.1 North America Imatinib Mesylate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Imatinib Mesylate Sales in Volume by Country (2018-2023)
5.1.3 North America Imatinib Mesylate Sales in Value by Country (2018-2023)
5.2 North America Imatinib Mesylate Forecasted Market Size by Country
5.2.1 North America Imatinib Mesylate Sales in Volume by Country (2024-2029)
5.2.2 North America Imatinib Mesylate Sales in Value by Country (2024-2029)
6 Europe Imatinib Mesylate by Country
6.1 Europe Imatinib Mesylate Historic Market Size by Country
6.1.1 Europe Imatinib Mesylate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Imatinib Mesylate Sales in Volume by Country (2018-2023)
6.1.3 Europe Imatinib Mesylate Sales in Value by Country (2018-2023)
6.2 Europe Imatinib Mesylate Forecasted Market Size by Country
6.2.1 Europe Imatinib Mesylate Sales in Volume by Country (2024-2029)
6.2.2 Europe Imatinib Mesylate Sales in Value by Country (2024-2029)
7 Asia-Pacific Imatinib Mesylate by Region
7.1 Asia-Pacific Imatinib Mesylate Historic Market Size by Region
7.1.1 Asia-Pacific Imatinib Mesylate Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Imatinib Mesylate Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Imatinib Mesylate Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Imatinib Mesylate Forecasted Market Size by Region
7.2.1 Asia-Pacific Imatinib Mesylate Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Imatinib Mesylate Sales in Value by Region (2024-2029)
8 Latin America Imatinib Mesylate by Country
8.1 Latin America Imatinib Mesylate Historic Market Size by Country
8.1.1 Latin America Imatinib Mesylate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Imatinib Mesylate Sales in Volume by Country (2018-2023)
8.1.3 Latin America Imatinib Mesylate Sales in Value by Country (2018-2023)
8.2 Latin America Imatinib Mesylate Forecasted Market Size by Country
8.2.1 Latin America Imatinib Mesylate Sales in Volume by Country (2024-2029)
8.2.2 Latin America Imatinib Mesylate Sales in Value by Country (2024-2029)
9 Middle East and Africa Imatinib Mesylate by Country
9.1 Middle East and Africa Imatinib Mesylate Historic Market Size by Country
9.1.1 Middle East and Africa Imatinib Mesylate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Imatinib Mesylate Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Imatinib Mesylate Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Imatinib Mesylate Forecasted Market Size by Country
9.2.1 Middle East and Africa Imatinib Mesylate Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Imatinib Mesylate Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GLEEVEC
10.1.1 GLEEVEC Company Information
10.1.2 GLEEVEC Introduction and Business Overview
10.1.3 GLEEVEC Imatinib Mesylate Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GLEEVEC Imatinib Mesylate Products Offered
10.1.5 GLEEVEC Recent Development
10.2 Cayman Chemical
10.2.1 Cayman Chemical Company Information
10.2.2 Cayman Chemical Introduction and Business Overview
10.2.3 Cayman Chemical Imatinib Mesylate Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Cayman Chemical Imatinib Mesylate Products Offered
10.2.5 Cayman Chemical Recent Development
10.3 Sichuan Xieli
10.3.1 Sichuan Xieli Company Information
10.3.2 Sichuan Xieli Introduction and Business Overview
10.3.3 Sichuan Xieli Imatinib Mesylate Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Sichuan Xieli Imatinib Mesylate Products Offered
10.3.5 Sichuan Xieli Recent Development
10.4 Nanjing Kaihua Chemical
10.4.1 Nanjing Kaihua Chemical Company Information
10.4.2 Nanjing Kaihua Chemical Introduction and Business Overview
10.4.3 Nanjing Kaihua Chemical Imatinib Mesylate Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Nanjing Kaihua Chemical Imatinib Mesylate Products Offered
10.4.5 Nanjing Kaihua Chemical Recent Development
10.5 Zhengda Tianqing
10.5.1 Zhengda Tianqing Company Information
10.5.2 Zhengda Tianqing Introduction and Business Overview
10.5.3 Zhengda Tianqing Imatinib Mesylate Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Zhengda Tianqing Imatinib Mesylate Products Offered
10.5.5 Zhengda Tianqing Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Imatinib Mesylate Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Imatinib Mesylate Industrial Chain Analysis
11.4 Imatinib Mesylate Market Dynamics
11.4.1 Imatinib Mesylate Industry Trends
11.4.2 Imatinib Mesylate Market Drivers
11.4.3 Imatinib Mesylate Market Challenges
11.4.4 Imatinib Mesylate Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Imatinib Mesylate Distributors
12.3 Imatinib Mesylate Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
    Table 1. Major Company of 99% Purity
    Table 2. Major Company of 98% Purity
    Table 3. Major Company of Other
    Table 4. Global Imatinib Mesylate Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 5. Global Imatinib Mesylate Sales by Type (2018-2023) & (MT)
    Table 6. Global Imatinib Mesylate Sales Market Share in Volume by Type (2018-2023)
    Table 7. Global Imatinib Mesylate Sales by Type (2018-2023) & (US& Million)
    Table 8. Global Imatinib Mesylate Market Share in Value by Type (2018-2023)
    Table 9. Global Imatinib Mesylate Price by Type (2018-2023) & (USD/MT)
    Table 10. Global Imatinib Mesylate Sales by Type (2024-2029) & (MT)
    Table 11. Global Imatinib Mesylate Sales Market Share in Volume by Type (2024-2029)
    Table 12. Global Imatinib Mesylate Sales by Type (2024-2029) & (US$ Million)
    Table 13. Global Imatinib Mesylate Sales Market Share in Value by Type (2024-2029)
    Table 14. Global Imatinib Mesylate Price by Type (2024-2029) & (USD/MT)
    Table 15. North America Imatinib Mesylate Sales by Type (2018-2023) & (MT)
    Table 16. North America Imatinib Mesylate Sales by Type (2018-2023) & (US$ Million)
    Table 17. Europe Imatinib Mesylate Sales (MT) by Type (2018-2023)
    Table 18. Europe Imatinib Mesylate Sales by Type (2018-2023) & (US$ Million)
    Table 19. Asia-Pacific Imatinib Mesylate Sales (MT) by Type (2018-2023)
    Table 20. Asia-Pacific Imatinib Mesylate Sales by Type (2018-2023) & (US$ Million)
    Table 21. Latin America Imatinib Mesylate Sales (MT) by Type (2018-2023)
    Table 22. Latin America Imatinib Mesylate Sales by Type (2018-2023) & (US$ Million)
    Table 23. Middle East and Africa Imatinib Mesylate Sales (MT) by Type (2018-2023)
    Table 24. Middle East and Africa Imatinib Mesylate Sales by Type (2018-2023) & (US$ Million)
    Table 25. Global Imatinib Mesylate Sales by Company (2018-2023) & (MT)
    Table 26. Global Imatinib Mesylate Sales Share by Company (2018-2023)
    Table 27. Global Imatinib Mesylate Revenue by Company (2018-2023) & (US$ Million)
    Table 28. Global Imatinib Mesylate Revenue Share by Company (2018-2023)
    Table 29. Global Market Imatinib Mesylate Price by Company (2018-2023) & (USD/MT)
    Table 30. Global Imatinib Mesylate Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 31. Global Imatinib Mesylate Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Imatinib Mesylate as of 2022)
    Table 33. Date of Key Manufacturers Enter into Imatinib Mesylate Market
    Table 34. Key Manufacturers Imatinib Mesylate Product Type
    Table 35. Mergers & Acquisitions, Expansion Plans
    Table 36. Global Imatinib Mesylate Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 37. Global Imatinib Mesylate Sales by Region (2018-2023) & (MT)
    Table 38. Global Imatinib Mesylate Sales Market Share in Volume by Region (2018-2023)
    Table 39. Global Imatinib Mesylate Sales by Region (2018-2023) & (US$ Million)
    Table 40. Global Imatinib Mesylate Sales Market Share in Value by Region (2018-2023)
    Table 41. Global Imatinib Mesylate Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 42. Global Imatinib Mesylate Sales by Region (2024-2029) & (MT)
    Table 43. Global Imatinib Mesylate Sales Market Share in Volume by Region (2024-2029)
    Table 44. Global Imatinib Mesylate Sales by Region (2024-2029) & (US$ Million)
    Table 45. Global Imatinib Mesylate Sales Market Share in Value by Region (2024-2029)
    Table 46. Global Imatinib Mesylate Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2029)
    Table 47. Global Imatinib Mesylate Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 48. Global Imatinib Mesylate Sales by Application (2018-2023) & (MT)
    Table 49. Global Imatinib Mesylate Sales Market Share in Volume by Application (2018-2023)
    Table 50. Global Imatinib Mesylate Sales by Application (2018-2023) & (US$ Million)
    Table 51. Global Imatinib Mesylate Sales Market Share in Value by Application (2018-2023)
    Table 52. Global Imatinib Mesylate Price by Application (2018-2023) & (USD/MT)
    Table 53. Global Imatinib Mesylate Sales by Application (2024-2029) & (MT)
    Table 54. Global Imatinib Mesylate Sales Market Share in Volume by Application (2024-2029)
    Table 55. Global Imatinib Mesylate Sales by Application (2024-2029) & (US$ Million)
    Table 56. Global Imatinib Mesylate Sales Market Share in Value by Application (2024-2029)
    Table 57. Global Imatinib Mesylate Price by Application (2024-2029) & (USD/MT)
    Table 58. North America Imatinib Mesylate Sales by Application (2018-2023) (MT)
    Table 59. North America Imatinib Mesylate Sales by Application (2018-2023) & (US$ Million)
    Table 60. Europe Imatinib Mesylate Sales by Application (2018-2023) (MT)
    Table 61. Europe Imatinib Mesylate Sales by Application (2018-2023) & (US$ Million)
    Table 62. Asia-Pacific Imatinib Mesylate Sales by Application (2018-2023) (MT)
    Table 63. Asia-Pacific Imatinib Mesylate Sales by Application (2018-2023) & (US$ Million)
    Table 64. Latin America Imatinib Mesylate Sales by Application (2018-2023) (MT)
    Table 65. Latin America Imatinib Mesylate Sales by Application (2018-2023) & (US$ Million)
    Table 66. Middle East and Africa Imatinib Mesylate Sales by Application (2018-2023) (MT)
    Table 67. Middle East and Africa Imatinib Mesylate Sales by Application (2018-2023) & (US$ Million)
    Table 68. North America Imatinib Mesylate Sales by Country (2018-2023) & (MT)
    Table 69. North America Imatinib Mesylate Sales Market Share in Volume by Country (2018-2023)
    Table 70. North America Imatinib Mesylate Sales by Country (2018-2023) & (US$ Million)
    Table 71. North America Imatinib Mesylate Sales Market Share in Value by Country (2018-2023)
    Table 72. North America Imatinib Mesylate Sales by Country (2024-2029) & (MT)
    Table 73. North America Imatinib Mesylate Sales Market Share in Volume by Country (2024-2029)
    Table 74. North America Imatinib Mesylate Sales by Country (2024-2029) & (US$ Million)
    Table 75. North America Imatinib Mesylate Sales Market Share in Value by Country (2024-2029)
    Table 76. Europe Imatinib Mesylate Sales by Country (2018-2023) & (MT)
    Table 77. Europe Imatinib Mesylate Sales Market Share in Volume by Country (2018-2023)
    Table 78. Europe Imatinib Mesylate Sales by Country (2018-2023) & (US$ Million)
    Table 79. Europe Imatinib Mesylate Sales Market Share in Value by Country (2018-2023)
    Table 80. Europe Imatinib Mesylate Sales by Country (2024-2029) & (MT)
    Table 81. Europe Imatinib Mesylate Sales Market Share in Volume by Country (2024-2029)
    Table 82. Europe Imatinib Mesylate Sales by Country (2024-2029) & (US$ Million)
    Table 83. Europe Imatinib Mesylate Sales Market Share in Value by Country (2024-2029)
    Table 84. Asia-Pacific Imatinib Mesylate Sales by Region (2018-2023) & (MT)
    Table 85. Asia-Pacific Imatinib Mesylate Sales Market Share in Volume by Region (2018-2023)
    Table 86. Asia-Pacific Imatinib Mesylate Sales by Region (2018-2023) & (US$ Million)
    Table 87. Asia-Pacific Imatinib Mesylate Sales Market Share in Value by Region (2018-2023)
    Table 88. Asia-Pacific Imatinib Mesylate Sales by Region (2024-2029) & (MT)
    Table 89. Asia-Pacific Imatinib Mesylate Sales Market Share in Volume by Region (2024-2029)
    Table 90. Asia-Pacific Imatinib Mesylate Sales by Region (2024-2029) & (US$ Million)
    Table 91. Asia-Pacific Imatinib Mesylate Sales Market Share in Value by Region (2024-2029)
    Table 92. Latin America Imatinib Mesylate Sales by Country (2018-2023) & (MT)
    Table 93. Latin America Imatinib Mesylate Sales Market Share in Volume by Country (2018-2023)
    Table 94. Latin America Imatinib Mesylate Sales by Country (2018-2023) & (US$ Million)
    Table 95. Latin America Imatinib Mesylate Sales Market Share in Value by Country (2018-2023)
    Table 96. Latin America Imatinib Mesylate Sales by Country (2024-2029) & (MT)
    Table 97. Latin America Imatinib Mesylate Sales Market Share in Volume by Country (2024-2029)
    Table 98. Latin America Imatinib Mesylate Sales by Country (2024-2029) & (US$ Million)
    Table 99. Latin America Imatinib Mesylate Sales Market Share in Value by Country (2024-2029)
    Table 100. Middle East and Africa Imatinib Mesylate Sales by Country (2018-2023) & (MT)
    Table 101. Middle East and Africa Imatinib Mesylate Sales Market Share in Volume by Country (2018-2023)
    Table 102. Middle East and Africa Imatinib Mesylate Sales by Country (2018-2023) & (US$ Million)
    Table 103. Middle East and Africa Imatinib Mesylate Sales Market Share in Value by Country (2018-2023)
    Table 104. Middle East and Africa Imatinib Mesylate Sales by Country (2024-2029) & (MT)
    Table 105. Middle East and Africa Imatinib Mesylate Sales Market Share in Volume by Country (2024-2029)
    Table 106. Middle East and Africa Imatinib Mesylate Sales by Country (2024-2029) & (US$ Million)
    Table 107. Middle East and Africa Imatinib Mesylate Sales Market Share in Value by Country (2024-2029)
    Table 108. GLEEVEC Company Information
    Table 109. GLEEVEC Introduction and Business Overview
    Table 110. GLEEVEC Imatinib Mesylate Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 111. GLEEVEC Imatinib Mesylate Product
    Table 112. GLEEVEC Recent Development
    Table 113. Cayman Chemical Company Information
    Table 114. Cayman Chemical Introduction and Business Overview
    Table 115. Cayman Chemical Imatinib Mesylate Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 116. Cayman Chemical Imatinib Mesylate Product
    Table 117. Cayman Chemical Recent Development
    Table 118. Sichuan Xieli Company Information
    Table 119. Sichuan Xieli Introduction and Business Overview
    Table 120. Sichuan Xieli Imatinib Mesylate Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 121. Sichuan Xieli Imatinib Mesylate Product
    Table 122. Sichuan Xieli Recent Development
    Table 123. Nanjing Kaihua Chemical Company Information
    Table 124. Nanjing Kaihua Chemical Introduction and Business Overview
    Table 125. Nanjing Kaihua Chemical Imatinib Mesylate Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 126. Nanjing Kaihua Chemical Imatinib Mesylate Product
    Table 127. Nanjing Kaihua Chemical Recent Development
    Table 128. Zhengda Tianqing Company Information
    Table 129. Zhengda Tianqing Introduction and Business Overview
    Table 130. Zhengda Tianqing Imatinib Mesylate Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 131. Zhengda Tianqing Imatinib Mesylate Product
    Table 132. Zhengda Tianqing Recent Development
    Table 133. Key Raw Materials Lists
    Table 134. Raw Materials Key Suppliers Lists
    Table 135. Imatinib Mesylate Market Trends
    Table 136. Imatinib Mesylate Market Drivers
    Table 137. Imatinib Mesylate Market Challenges
    Table 138. Imatinib Mesylate Market Restraints
    Table 139. Imatinib Mesylate Distributors List
    Table 140. Imatinib Mesylate Downstream Customers
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Imatinib Mesylate Product Picture
    Figure 2. Global Imatinib Mesylate Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Imatinib Mesylate Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Imatinib Mesylate Sales Status and Outlook (2018-2029) & (MT)
    Figure 5. Product Picture of 99% Purity
    Figure 6. Global 99% Purity Sales YoY Growth (2018-2029) & (MT)
    Figure 7. Product Picture of 98% Purity
    Figure 8. Global 98% Purity Sales YoY Growth (2018-2029) & (MT)
    Figure 9. Product Picture of Other
    Figure 10. Global Other Sales YoY Growth (2018-2029) & (MT)
    Figure 11. Global Imatinib Mesylate Sales by Type (2018-2029) & (US$ Million)
    Figure 12. Global Imatinib Mesylate Sales Market Share by Type in 2022 & 2029
    Figure 13. North America Imatinib Mesylate Sales Market Share in Volume by Type in 2022
    Figure 14. North America Imatinib Mesylate Sales Market Share in Value by Type in 2022
    Figure 15. Europe Imatinib Mesylate Sales Market Share in Volume by Type in 2022
    Figure 16. Europe Imatinib Mesylate Sales Market Share in Value by Type in 2022
    Figure 17. Asia-Pacific Imatinib Mesylate Sales Market Share in Volume by Type in 2022
    Figure 18. Asia-Pacific Imatinib Mesylate Sales Market Share in Value by Type in 2022
    Figure 19. Latin America Imatinib Mesylate Sales Market Share in Volume by Type in 2022
    Figure 20. Latin America Imatinib Mesylate Sales Market Share in Value by Type in 2022
    Figure 21. Middle East and Africa Imatinib Mesylate Sales Market Share in Volume by Type in 2022
    Figure 22. Middle East and Africa Imatinib Mesylate Sales Market Share in Value by Type in 2022
    Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Imatinib Mesylate Sales in 2022
    Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Imatinib Mesylate Revenue in 2022
    Figure 25. Imatinib Mesylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 26. Product Picture of CML
    Figure 27. Global CML Sales YoY Growth (2018-2029) & (MT)
    Figure 28. Product Picture of GIST
    Figure 29. Global GIST Sales YoY Growth (2018-2029) & (MT)
    Figure 30. Product Picture of Other
    Figure 31. Global Other Sales YoY Growth (2018-2029) & (MT)
    Figure 32. Global Imatinib Mesylate Sales by Application (2018-2029) & (US$ Million)
    Figure 33. Global Imatinib Mesylate Sales Market Share by Application in 2022 & 2029
    Figure 34. North America Imatinib Mesylate Sales Market Share in Volume by Application in 2022
    Figure 35. North America Imatinib Mesylate Sales Market Share in Value by Application in 2022
    Figure 36. Europe Imatinib Mesylate Sales Market Share in Volume by Application in 2022
    Figure 37. Europe Imatinib Mesylate Sales Market Share in Value by Application in 2022
    Figure 38. Asia-Pacific Imatinib Mesylate Sales Market Share in Volume by Application in 2022
    Figure 39. Asia-Pacific Imatinib Mesylate Sales Market Share in Value by Application in 2022
    Figure 40. Latin America Imatinib Mesylate Sales Market Share in Volume by Application in 2022
    Figure 41. Latin America Imatinib Mesylate Sales Market Share in Value by Application in 2022
    Figure 42. Middle East and Africa Imatinib Mesylate Sales Market Share in Value by Application in 2022
    Figure 43. Key Raw Materials Price
    Figure 44. Imatinib Mesylate Manufacturing Cost Structure
    Figure 45. Imatinib Mesylate Industrial Chain Analysis
    Figure 46. Channels of Distribution
    Figure 47. Distributors Profiles
    Figure 48. Bottom-up and Top-down Approaches for This Report
    Figure 49. Data Triangulation
    Figure 50. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS